ArticleJournal of dermato-oncology2026
Blue light and ultraviolet radiation: comparative biophysical properties and their roles in skin carcinogenesis and photoaging.
Article in Journal of dermato-oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Ultraviolet radiation (UVR), especially UVB and UVA, drives photoaging and carcinogenesis, whereas blue light (BL, 400-500 nm) remains less studied. Evidence shows BL induces melanogenesis, generates reactive oxygen species, impairs deoxyribonucleic acid (DNA) repair, and accelerates pigmentation and oxidative stress. Though not directly linked to skin cancer, BL amplifies UVR damage and hastens photoaging, yet also suppresses tumor growth by promoting apoptosis, revealing dual context-dependent effects. This review highlights BL's biological and clinical relevance, phototype-dependent responses, and mechanistic uncertainties. Expanding photoprotection beyond UVR to include BL is essential for comprehensive, evidence-based strategies safeguarding skin health across diverse populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.